Felbatol

CARTER-WALLACE CARTER PRODUCTS DIV -- 24F5 FELBATOL ORAL SUSPENSION 8 OZ -- 6505-01-381-1399
=======================================================
MSDS Safety Information 
=======================================================
FSC: 6505
NIIN: 01-381-1399
MSDS Date: 10/14/1994
MSDS Num: BXPDW
Tech Review: 08/03/1995
Product ID: 24F5 FELBATOL ORAL SUSPENSION 8 OZ
Responsible Party
Cage: 6J964
Name: CARTER-WALLACE INC CARTER PRODUCTS DIV
Box: 1001
City: CRANBURY NJ 08512-0181 US
Info Phone Number: 609-655-6592
Emergency Phone Number: 609-655-6474
=======================================================
Preparer Co. when other than Responsible Party Co. 
=======================================================
Cage: 6J964
Assigned Ind: N
Name: CARTER-WALLACE INC
City: CRANBURY NJ 08512
=======================================================
Contractor Summary 
=======================================================
Cage: 6J964
Name: CARTER-WALLACE INC
City: CRANBURY NJ 08512 US
Phone: (609) 655-6000
=======================================================
Item Description Information 
=======================================================
Item Name: FELBAMATE ORAL SUSPENSION
Specification Number: NK
Type/Grade/Class: NK
Unit of Issue: BT
Quantitative Expression: 00000000240ML
UI Container Qty: 1
=======================================================
Ingredients 
=======================================================
Cas: 25451-15-4
RTECS #: TZ0700000
Name: 1,3-PROPANEDIOL, 2-PHENYL-, DICARBAMATE	      *95-2*
=======================================================
Health Hazards Data 
=======================================================
LD50 LC50 Mixture: ORAL LD50 (RAT): 5000 MG/KG
Route Of Entry Inds - Inhalation: NO
Skin: NO
Ingestion: YES
Carcinogenicity Inds - NTP: NO
IARC: NO
OSHA: NO
Effects of Exposure: EXPOSURE TO PREGNANT WOMEN SHOULD BE LIMITED. THE
  ONLY ADVERSE EXPERIENCES REPORTED WERE MILD GASTRIC DISTRESS & RESTING
  HEART RATE OF 100 BPM. MASSIVE FELBAMATE OVERDOSE COULD PRODUCE CNS
  DEPRESSION.
Explanation Of Carcinogenicity: NONE
Signs And Symptions Of Overexposure: GASTRIC DISTRESS, DECREASED MUSCLE
  TONE, TREMORS, ATAXIA.
Medical Cond Aggravated By Exposure: HYPERSENSITIVITY IS POSSIBLE.
  EXPOSURE TO FELBAMATE SHOULD BE LIMITED IN THOSE WHO HAVE DEMONSTRATED
  HYPERSENSITIVITY REACTIONS TO OTHER CARBAMATES.
First Aid: INGESTION: ANY DRUG REMAINING IN STOMACH SHOULD BE REMOVED.
  VIGOROUS THERAPY SHOULD BE INITIATED ONLY IF RESPIRATION & BLOOD
  PRESSURE ARE COMPROMISED. OBSERVE TO POSSIBLE RELAPSE DUE TO INCOMPLETE
  GAS TRIC EMPTYING & DELAYED ABSORPTION. IT'S NOT KNOW IF FELBAMATE IS
  DIALYZABLE. FELBAMATE CAN BE MEASURED IN BLOOD BY HPLC. EYE: FLUSH
  W/PLENTY OF WATER. OBTAIN MEDICAL ATTENTION IN ALL CASES.
=======================================================
Handling and Disposal
=======================================================
Spill Release Procedures: PICK UP IN MOST EFFICIENT MANNER.
Waste Disposal Methods: PLACE MATERIAL IN A SEALED CONTAINER & DISPOSE OF
  IAW/ENVIRONMENTAL REGULATIONS.
Handling And Storage Precautions: STORE AT CONTROLLED ROOM TEMP (59-86F)
  IN A TIGHT CONTAINER AWAY FROM EXCESSIVE HEAT, DIRECT SUNLIGHT/MOISTURE.
Other Precautions: ALWAYS FOLLOW PRUDENT LABORATORY PRACTICES. CONSULT THE
  PACKAGE INSERT FOR FURTHER INFORMATION.
=======================================================
Fire and Explosion Hazard Information 
=======================================================
Extinguishing Media: USE MEDIA APPROPRIATE FOR SURROUNDING AREAS.
Unusual Fire/Explosion Hazard: NO UNUSUAL FIRE/EXPLOSION HAZARDS. MAY BURN
  BUT DOESN'T READILY IGNITE.
=======================================================
Control Measures 
=======================================================
Ventilation: GENERAL VENTILATION
=======================================================
Physical/Chemical Properties 
=======================================================
Solubility in Water: SLIGHTLY SOLUBLE
Appearance and Odor: PEACH-COLORED SUSPENSION IN BOTTLES.
=======================================================
Reactivity Data 
=======================================================
Stability Indicator: YES
Stability Condition To Avoid: EXCESSIVE HEAT, DIRECT SUNLIGHT, MOISTURE.
Hazardous Decomposition Products: NITROGEN COMPOUNDS (INCLUDING AMMONIA),
  CO, CO2.
Hazardous Polymerization Indicator: NO
=======================================================
Toxicological Information 
=======================================================
=======================================================
Ecological Information 
=======================================================
=======================================================
MSDS Transport Information 
=======================================================
=======================================================
Regulatory Information 
=======================================================
=======================================================
Other Information 
=======================================================
=======================================================
HAZCOM Label 
=======================================================
Product ID: 24F5 FELBATOL ORAL SUSPENSION 8 OZ
Cage: 6J964
Company Name: CARTER-WALLACE INC
City: CRANBURY NJ
Zipcode: 08512 US
Health Emergency Phone: 609-655-6474
Date Of Label Review: 12/16/1998
Label Date: 12/16/1998
Hazard And Precautions: EXPOSURE TO PREGNANT WOMEN SHOULD BE LIMITED. THE
  ONLY ADVERSE EXPERIENCES REPORTED WERE MILD GASTRIC DISTRESS & RESTING
  HEART RATE OF 100 BPM. MASSIVE FELBAMATE OVERDOSE COULD PRODUCE CNS
  DEPRESSION.								  
		     GASTRIC DISTRESS, DECREASED MUSCLE TONE, TREMORS,
  ATAXIA.
=======================================================
Disclaimer (provided with this information by the compiling agencies):
  This information is formulated for use by elements of the Department of
  Defense. The United States of America in no manner whatsoever expressly
  or implied warrants, states, or intends said information to have any
  application, use or viability by or to any person or persons outside the
  Department of Defense nor any person or persons contracting with any
  instrumentality of the United States of America and disclaims all
  liability for such use. Any person utilizing this instruction who is not
  a military or civilian employee of the United States of America should
  seek competent professional advice to verify and assume responsibility
  for the suitability of this information to their particular situation
  regardless of similarity to a corresponding Department of Defense or
  other government situation.